Jenburkt Pharmaceuticals

Stock Price vs Company Growth
1d
7.3%
1w
10.6%
1m
9.5%
3m
24.5%
6m
34.9%
1y
70.2%
5y
22.3%
10y
14.2%
all
22.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,087 7.3%
873
1,210
Company Overview

Sales
148 Cr
Growth: 7.6%
Profit after Tax
30.3 Cr
Growth: 8.1%
Small Cap
480 Cr
P/E: 15.8x
Industry P/E: 40.9x
Fundamentals

Sales (Cr) ₹ 148
Growth 7.6%
EBITDA 25.5%
P/S 3.2x
Dividend 1.9%
P/E 15.8x
Book Value ₹ 444
PEG Ratio 2.1x
ROE 16.5%
P/B 2.4x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Jenburkt Pharmaceuticals Ltd, a venture to diversify into the healthcare and pharmaceutical industry, was formed in 1985 by the Bhuta family; late Hemendra N. Bhuta was the promoter of the company while the Bhuta Group was founded by Nandlal Mulji BhutaJenburkt is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Jenburkt is a public limited company, with its stock listed on the Bombay Stock Exchange.
Investors (12)